TOBIN JAMES R — SEC insider filings

SEC reporting owner CIK 1190128. 38 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2020-08-26 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
TransMedics Group, Inc. (TMDX)Director20—22 legs · 240,218 sh · $14,671,98412
GLOBUS MEDICAL INC (GMED)Director13—9 legs · 143,000 sh · $10,035,63430
Oxford Immunotec Global PLC (OXFD)Director1——9
Lyra Therapeutics, Inc. (LYRA)Director4——4

Insider filings — TOBIN JAMES R

FiledFormIssuerReported transactionsSource
2026-11-124TransMedics Group, Inc. (TMDX)Sale (S): 59 @ $93.96 · Sale (S): 4,000 @ $94.98EDGAR
2026-11-124GLOBUS MEDICAL INC (GMED)Option exercise (M): 15,000 @ $65.05 · Option exercise (M): 21,458 @ $53.27 · Option exercise (M): 5,208 @ $43.58 · Sale (S): 37,662 @ $75.10 · Sale (S): 4,004 @ $75.68 · Option exercise (M): 15,000 (derivative) @ $0 · +2 moreEDGAR
2026-09-164GLOBUS MEDICAL INC (GMED)Option exercise (M): 15,000 @ $53.75 · Option exercise (M): 15,000 @ $63.68 · Sale (S): 30,000 @ $74.58 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-08-174TransMedics Group, Inc. (TMDX)Gift (G): 18,000 @ $0EDGAR
2026-05-224TransMedics Group, Inc. (TMDX)Grant/award (A): 2,922 @ $0EDGAR
2026-01-234GLOBUS MEDICAL INC (GMED)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-05-234TransMedics Group, Inc. (TMDX)Grant/award (A): 2,134 @ $0EDGAR
2025-05-164Lyra Therapeutics, Inc. (LYRA)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2025-03-284GLOBUS MEDICAL INC (GMED)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-09-174TransMedics Group, Inc. (TMDX)Gift (G): 18,000 @ $0 · Gift (G): 18,000 @ $0EDGAR
2024-08-094TransMedics Group, Inc. (TMDX)Sale (S): 12,664 @ $158.96 · Sale (S): 7,336 @ $159.96EDGAR
2024-06-144Lyra Therapeutics, Inc. (LYRA)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-05-284TransMedics Group, Inc. (TMDX)Grant/award (A): 732 @ $0 · Grant/award (A): 1,154 (derivative) @ $0EDGAR
2024-05-074TransMedics Group, Inc. (TMDX)Sale (S): 5,130 @ $124.76 · Sale (S): 6,895 @ $125.26EDGAR
2024-05-034TransMedics Group, Inc. (TMDX)Sale (S): 11,236 @ $105.70 · Sale (S): 1,704 @ $106.89 · Sale (S): 100 @ $108.47 · Sale (S): 2,000 @ $110EDGAR
2024-03-054TransMedics Group, Inc. (TMDX)Sale (S): 200 @ $81.41 · Sale (S): 4,234 @ $82.84 · Sale (S): 5,746 @ $83.63 · Sale (S): 2,900 @ $84.74 · Sale (S): 300 @ $85.48EDGAR
2024-01-304GLOBUS MEDICAL INC (GMED)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-11-294TransMedics Group, Inc. (TMDX)Sale (S): 10,000 @ $70.14EDGAR
2023-07-054Lyra Therapeutics, Inc. (LYRA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-05-304TransMedics Group, Inc. (TMDX)Grant/award (A): 1,193 @ $0 · Grant/award (A): 1,916 (derivative) @ $0EDGAR
2023-02-274TransMedics Group, Inc. (TMDX)Sale (S): 10,000 @ $75.13EDGAR
2023-02-274GLOBUS MEDICAL INC (GMED)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-08-014TransMedics Group, Inc. (TMDX)Sale (S): 48,515 @ $39.98EDGAR
2022-07-064TransMedics Group, Inc. (TMDX)Sale (S): 48,515 @ $35EDGAR
2022-06-064TransMedics Group, Inc. (TMDX)Grant/award (A): 13,500 (derivative) @ $0EDGAR
2022-05-064TransMedics Group, Inc. (TMDX)Sale (S): 48,516 @ $29.94EDGAR
2022-03-174GLOBUS MEDICAL INC (GMED)Option exercise (M): 5,308 @ $43.58 · Option exercise (M): 3,542 @ $53.27 · Sale (S): 8,850 @ $65.47 · Option exercise (M): 5,308 (derivative) @ $0 · Option exercise (M): 3,542 (derivative) @ $0EDGAR
2022-03-104GLOBUS MEDICAL INC (GMED)Option exercise (M): 4,484 @ $43.58 · Sale (S): 4,484 @ $72 · Option exercise (M): 10,000 @ $43.58 · Sale (S): 10,000 @ $70.04 · Option exercise (M): 4,484 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2022-03-084Lyra Therapeutics, Inc. (LYRA)Grant/award (A): 14,500 (derivative) @ $0EDGAR
2022-01-314GLOBUS MEDICAL INC (GMED)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-12-164TransMedics Group, Inc. (TMDX)Gift (G): 25,500 @ $0EDGAR
2021-06-014TransMedics Group, Inc. (TMDX)Grant/award (A): 13,500 (derivative) @ $0EDGAR
2021-05-124GLOBUS MEDICAL INC (GMED)Option exercise (M): 25,000 @ $43.77 · Sale (S): 25,000 @ $71.96 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2021-03-124Oxford Immunotec Global PLC (OXFD)Disposition to issuer (D): 4,081 @ $22 · Disposition to issuer (D): 7,457 (derivative) @ $13.35 · Disposition to issuer (D): 7,457 (derivative) @ $7.54 · Disposition to issuer (D): 7,457 (derivative) @ $7.51 · Disposition to issuer (D): 7,457 (derivative) @ $7.56 · Disposition to issuer (D): 14,914 (derivative) @ $8.98 · +3 moreEDGAR
2021-02-104TransMedics Group, Inc. (TMDX)Sale (S): 9,968 @ $32.80 · Sale (S): 200 @ $34.18EDGAR
2021-01-194GLOBUS MEDICAL INC (GMED)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2020-09-034GLOBUS MEDICAL INC (GMED)Option exercise (M): 5,600 @ $26.27 · Sale (S): 5,600 @ $56.85 · Option exercise (M): 5,600 (derivative) @ $0EDGAR
2020-08-264GLOBUS MEDICAL INC (GMED)Option exercise (M): 17,400 @ $26.27 · Sale (S): 17,400 @ $54.40 · Option exercise (M): 17,400 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1190128 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs